Key result
Supra-annular Bravo 300 implantation is linked to low postoperative gradients in ~95% of patients vs intra-annular.
Why the study?
Does supra-annular implantation improve early haemodynamic outcomes compared to intra-annular implantation in patients receiving stentless Bravo model 300 valves?
Cohort (n=200)
Does supra-annular implantation improve early haemodynamic outcomes compared to intra-annular implantation in patients receiving stentless Bravo model 300 valves?
Absolute Event Rate: 95% vs 24%
p-value: p=<0.001
Supra-annular implantation of the stentless Bravo 300 valve significantly improves early haemodynamic outcomes, including lower gradients and reduced regurgitation, compared to intra-annular implantation.
May support supra-annular technique for better early hemodynamics; leaves open durability, clinical outcomes, and need for randomized trials.
The aim of the study was to compare the supra-annular and intra-annular implantation techniques by evaluating the differences in early haemodynamic outcome (gradients, effective orifice area, regurgitation). Since August 1991, 200 stentless Bravo model 300 valves have been implanted. Patients were divided into three groups of consecutive cases: group 1 (n = 50) represents exclusively intra-annular implantation; group 2 (n = 50) is a transitional period: and group 3 (n = 100) comprises only patients with supra-annular implantation. Significant differences were found (P<0.001) in low postoperative gradients (mean < or = 10 mmHg): 24% in group 1, 42% in group 2, and 95% in group 3. Comparing groups 1 and 3, gradients were lower and effective orifice area was augmented in all valve sizes in group 3. Trivial central regurgitation was present in groups 1-3 (6%, 12% and 0% respectively). Peripheral regurgitation was trivial in 6%, 8% and 0% and mild to moderate in 4%, 2% and 0% (P<0.001).
No takes yet. Share an insight, caveat, or question.
U Hvass (1997) conducted a cohort in Aortic valve disease requiring replacement (n=200). Supra-annular implantation vs. Intra-annular implantation was evaluated on Low postoperative gradients (mean ≤ 10 mmHg) (p=<0.001). Supra-annular implantation of the stentless Bravo 300 aortic valve resulted in a significantly higher rate of low postoperative gradients compared to intra-annular implantation (95% vs 24%, P<0.001).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: